Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1977 1
1979 1
1980 2
1981 4
1982 1
1985 3
1986 2
1987 1
1990 1
1991 1
2002 1
2008 1
2009 2
2010 1
2013 4
2015 3
2016 1
2017 1
2018 2
2019 1
2020 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic Review.
Byon W, Garonzik S, Boyd RA, Frost CE. Byon W, et al. Among authors: frost ce. Clin Pharmacokinet. 2019 Oct;58(10):1265-1279. doi: 10.1007/s40262-019-00775-z. Clin Pharmacokinet. 2019. PMID: 31089975 Free PMC article. Review.
Medicinal self-poisoning and prescription frequency.
Forster DP, Frost CE. Forster DP, et al. Among authors: frost ce. Acta Psychiatr Scand. 1985 Jun;71(6):567-74. doi: 10.1111/j.1600-0447.1985.tb02550.x. Acta Psychiatr Scand. 1985. PMID: 3927659
Apixaban metabolism and pharmacokinetics after oral administration to humans.
Raghavan N, Frost CE, Yu Z, He K, Zhang H, Humphreys WG, Pinto D, Chen S, Bonacorsi S, Wong PC, Zhang D. Raghavan N, et al. Among authors: frost ce. Drug Metab Dispos. 2009 Jan;37(1):74-81. doi: 10.1124/dmd.108.023143. Epub 2008 Oct 2. Drug Metab Dispos. 2009. PMID: 18832478
Physicians and medical innovation.
Frost CE. Frost CE. Soc Sci Med. 1985;21(10):1193-8. doi: 10.1016/0277-9536(85)90179-0. Soc Sci Med. 1985. PMID: 4081820
First-in-human study to assess the safety, pharmacokinetics and pharmacodynamics of BMS-962212, a direct, reversible, small molecule factor XIa inhibitor in non-Japanese and Japanese healthy subjects.
Perera V, Luettgen JM, Wang Z, Frost CE, Yones C, Russo C, Lee J, Zhao Y, LaCreta FP, Ma X, Knabb RM, Seiffert D, DeSouza M, Mugnier P, Cirincione B, Ueno T, Frost RJA. Perera V, et al. Among authors: frost ce. Br J Clin Pharmacol. 2018 May;84(5):876-887. doi: 10.1111/bcp.13520. Epub 2018 Mar 5. Br J Clin Pharmacol. 2018. PMID: 29346838 Free PMC article. Clinical Trial.
34 results